{"id":4666,"date":"2019-04-05T17:44:46","date_gmt":"2019-04-05T12:14:46","guid":{"rendered":"https:\/\/www.delveinsight.com\/blog\/?p=4666"},"modified":"2021-10-12T11:06:22","modified_gmt":"2021-10-12T05:36:22","slug":"travelers-diarrhea-market-trend","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/travelers-diarrhea-market-trend","title":{"rendered":"\ufeffCurrent and Emerging therapies that change Traveler\u2019s Diarrhea Market"},"content":{"rendered":"\n<p class=\"has-drop-cap\"><strong>Traveler\u2019s Diarrhea<\/strong> is an intestinal infection, a digestive tract disorder that requires research as globally many tourists are affected by it. According to the <strong>United Nations World Tourism Organization,<\/strong> in 2004, around 25%-50% of approximately 34 million international travelers, who visited developing countries, and tropical areas like Latin America, the Caribbean, the Middle East, South, and Southeast Asia, and Africa, from more developed or industrialized countries, are expected to experience<a href=\"https:\/\/www.delveinsight.com\/report-store\/travelers-diarrhea-market\"> <strong>Traveler\u2019s Diarrhea <\/strong><\/a><strong>(TD)<\/strong> due to the consumption of food or water contaminated with fecal. <\/p>\n\n\n\n<p class=\"has-very-light-gray-background-color has-background\">According to\nDelveInsight\u2019s estimates, the EU5 and, the US accounts for approximately&nbsp; 43% of the total Incident cases out of all the\nTD cases in 7 major markets in 2017. Among the EU5 countries, the highest % of\ndiagnosed Traveler\u2019s Diarrhea incident population was in Germany followed by\nItaly based on the recent studies and data from registries in 2017.<\/p>\n\n\n\n<p>Although TD is not a fatal disease <g class=\"gr_ gr_5 gr-alert gr_gramm gr_inline_cards gr_run_anim Grammar replaceWithoutSep\" id=\"5\" data-gr-id=\"5\">but<\/g> it can cause serious morbidity if symptoms continue even after returning to the native country. &nbsp;And the <strong>Traveler\u2019s Diarrhea <\/strong>prevalence has resulted in an increase in the Traveler\u2019s diarrhea market. <\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-the-traveler-s-diarrhea-market\">&nbsp;<strong>The Traveler\u2019s Diarrhea Market <\/strong><\/h4>\n\n\n\n<p>The total <strong><a href=\"https:\/\/www.delveinsight.com\/report-store\/travelers-diarrhea-epidemiology-forecast\">Traveler\u2019s Diarrhea market<\/a><\/strong> size was USD 1,717 Million in 2017 for the major markets. DelveInsight\u2019s analysts estimate that it is expected to show positive growth in the upcoming years. The total Traveler\u2019s Diarrhea market is set to expand by 2028. The analysis shows that the US <strong>Traveler\u2019s Diarrhea market <\/strong>is expected to grow at a CAGR of 5.93% for the study period. This accounts for almost doubling of Traveler\u2019s Diarrhea market size by 2028 making it reach 3,106 Million by 2028.<br>The current US <strong>Traveler\u2019s Diarrhea\u2019s market <\/strong>is dominated by the use of <strong>antibiotics as they form the 1<sup>st<\/sup> line of treatment.<\/strong><\/p>\n\n\n\n<p><strong>Antibiotics<\/strong> such as <strong>fluoroquinolones<\/strong> comprising <strong>ciprofloxacin<\/strong>, <strong>ofloxacin<\/strong>, <strong>norfloxacin,<\/strong> and <strong>levofloxacin<\/strong>. Antibiotic therapy is recommended either with or without <strong>loperamide<\/strong> for travelers with moderate to severe symptoms. Antibiotics, anti-motility drugs (for symptomatic relief) and <strong>Dukarol<\/strong> (Vaccine) are extensively being used as an <strong>off label therapy<\/strong>. The current market also holds a single approved therapy <strong>Xifaxan<\/strong> by <strong>Salix Pharmaceuticals<\/strong>. <strong>The second line of treatment i.e.<\/strong> <strong>azithromycin<\/strong> provides a potential alternative to fluoroquinolones. <strong>Azithromycin<\/strong> is considered as a treatment of choice for children between the ages of 2 and 8 years and for pregnant women, for whom the use of <strong>fluoroquinolones<\/strong> is contraindicated. &nbsp;The treatment of traveler&#8217;s diarrhea includes <strong>Oral Hydration as it<\/strong> replenishment fluids and electrolytes to prevent and treat dehydration. Also, the most common treatments include <strong>bismuth <g class=\"gr_ gr_10 gr-alert gr_spell gr_inline_cards gr_run_anim ContextualSpelling\" id=\"10\" data-gr-id=\"10\">subsalicylate<\/g> <\/strong>and <strong>Synthetic opiates<\/strong> such as <strong>loperamide<\/strong> and <strong>diphenoxylate<\/strong> that can reduce the frequency of bowel movements. <\/p>\n\n\n\n<p>Not to be missed, <strong><a href=\"https:\/\/www.delveinsight.com\/report-store\/traveler-s-diarrhea-pipeline-insight\">traveler\u2019s Diarrhea pipeline<\/a><\/strong> has seen constant upgradations in past years. DelveInsight believes that the current market for Traveler\u2019s Diarrhea will increase in the upcoming years with the emergence of several upcoming therapies. A significant shift is expected in the <strong>Traveler\u2019s Diarrhea market <\/strong>because of the positive outcomes of several prevailing drugs by the companies, such as <strong>Scandinavian<\/strong> <strong>Biopharma<\/strong>, <strong>Procter<\/strong> <strong>and<\/strong> <strong>Gamble<\/strong>, etc. The <strong>Fast Track and<\/strong> <strong>QIDP<\/strong> <strong>designation<\/strong> <strong>holder<\/strong> <strong>Aemcolo\/Relafalk<\/strong> by <strong>Cosmo Pharmaceuticals <\/strong>which is set to launch in 2019. The late-stage product <strong>Bismuth Subsalicylate<\/strong> has emerged as a promising option to enter the market in 2021 for <strong>Traveler\u2019s Diarrhea. <\/strong>Another mid-stage product <strong>Etvax<\/strong> is a vaccine against diarrheal disease caused by <strong>ETEC<\/strong> expected to enter the market by 2023.<\/p>\n\n\n\n<p>Trends in the Traveler\u2019s Diarrhea Market have been changing over the past years. The emergence of new effective drugs will benefit the patients as earlier their options were limited.<\/p>\n\n\n\n<p class=\"has-very-light-gray-background-color has-background\">Request for Sample Pages <a href=\"https:\/\/www.delveinsight.com\/sample-request\/traveler-s-diarrhea-market-insights-epidemiology-and-market-forecast\">Traveler\u2019s Diarrhea Market<\/a>. <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Traveler\u2019s Diarrhea is an intestinal infection, a digestive tract disorder that requires research as globally many tourists are affected by it. According to the United Nations World Tourism Organization, in 2004, around 25%-50% of approximately 34 million international travelers, who visited developing countries, and tropical areas like Latin America, the Caribbean, the Middle East, South, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":4667,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[17,17434],"tags":[3017,3011,3021],"industry":[17225],"therapeutic_areas":[17239],"class_list":["post-4666","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","category-facts-and-figures","tag-travelers-diarrhea-pipeline","tag-travelers-diarrhea","tag-travelers-diarrhea-market","industry-pharmaceutical","therapeutic_areas-gastroenterology"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.8 (Yoast SEO v25.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Traveler\u2019s Diarrhea Market | Traveler\u2019s Diarrhea Pipeline Analysis<\/title>\n<meta name=\"description\" content=\"The analysis shows that the US Traveler\u2019s Diarrhea market is expected to grow at a CAGR of 5.93% for the study period. This accounts for almost doubling...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/travelers-diarrhea-market-trend\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Traveler\u2019s Diarrhea Market | Traveler\u2019s Diarrhea Pipeline Analysis\" \/>\n<meta property=\"og:description\" content=\"The analysis shows that the US Traveler\u2019s Diarrhea market is expected to grow at a CAGR of 5.93% for the study period. This accounts for almost doubling...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/travelers-diarrhea-market-trend\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-04-05T12:14:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-10-12T05:36:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/04\/09173015\/Traveler%E2%80%99s-Diarrhea-image.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"DelveInsight\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DelveInsight\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Traveler\u2019s Diarrhea Market | Traveler\u2019s Diarrhea Pipeline Analysis","description":"The analysis shows that the US Traveler\u2019s Diarrhea market is expected to grow at a CAGR of 5.93% for the study period. This accounts for almost doubling...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/travelers-diarrhea-market-trend","og_locale":"en_US","og_type":"article","og_title":"Traveler\u2019s Diarrhea Market | Traveler\u2019s Diarrhea Pipeline Analysis","og_description":"The analysis shows that the US Traveler\u2019s Diarrhea market is expected to grow at a CAGR of 5.93% for the study period. This accounts for almost doubling...","og_url":"https:\/\/www.delveinsight.com\/blog\/travelers-diarrhea-market-trend","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2019-04-05T12:14:46+00:00","article_modified_time":"2021-10-12T05:36:22+00:00","og_image":[{"width":1280,"height":720,"url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/04\/09173015\/Traveler%E2%80%99s-Diarrhea-image.png","type":"image\/png"}],"author":"DelveInsight","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"DelveInsight","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delveinsight.com\/blog\/travelers-diarrhea-market-trend","url":"https:\/\/www.delveinsight.com\/blog\/travelers-diarrhea-market-trend","name":"Traveler\u2019s Diarrhea Market | Traveler\u2019s Diarrhea Pipeline Analysis","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/travelers-diarrhea-market-trend#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/travelers-diarrhea-market-trend#primaryimage"},"thumbnailUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/04\/09173015\/Traveler%E2%80%99s-Diarrhea-image.png","datePublished":"2019-04-05T12:14:46+00:00","dateModified":"2021-10-12T05:36:22+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a"},"description":"The analysis shows that the US Traveler\u2019s Diarrhea market is expected to grow at a CAGR of 5.93% for the study period. This accounts for almost doubling...","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/travelers-diarrhea-market-trend"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/travelers-diarrhea-market-trend#primaryimage","url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/04\/09173015\/Traveler%E2%80%99s-Diarrhea-image.png","contentUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/04\/09173015\/Traveler%E2%80%99s-Diarrhea-image.png","width":1280,"height":720,"caption":"Traveler's Diarrhea market"},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a","name":"DelveInsight","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","caption":"DelveInsight"}}]}},"author_meta":{"display_name":"DelveInsight","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/gtadmin"},"featured_img":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/04\/09173015\/Traveler%E2%80%99s-Diarrhea-image-300x169.png","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Articles<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/facts-and-figures\/\" class=\"advgb-post-tax-term\">Facts and Figures<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Articles<\/span>","<span class=\"advgb-post-tax-term\">Facts and Figures<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/facts-and-figures\/\" class=\"advgb-post-tax-term\">Traveler&#039;s Diarrhea pipeline<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/facts-and-figures\/\" class=\"advgb-post-tax-term\">Traveler\u2019s diarrhea<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/facts-and-figures\/\" class=\"advgb-post-tax-term\">Traveler\u2019s diarrhea market<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Traveler&#039;s Diarrhea pipeline<\/span>","<span class=\"advgb-post-tax-term\">Traveler\u2019s diarrhea<\/span>","<span class=\"advgb-post-tax-term\">Traveler\u2019s diarrhea market<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 7 years ago","modified":"Updated 5 years ago"},"absolute_dates":{"created":"Posted on Apr 5, 2019","modified":"Updated on Oct 12, 2021"},"absolute_dates_time":{"created":"Posted on Apr 5, 2019 5:44 pm","modified":"Updated on Oct 12, 2021 11:06 am"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/4666","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=4666"}],"version-history":[{"count":0,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/4666\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media\/4667"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=4666"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=4666"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=4666"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=4666"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=4666"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}